Preventing deficiencies in pediatric food allergies
Distinguishing between food allergies and intolerances is crucial.
A preview of the April Allergy Awareness issue of Contemporary Pediatrics
Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the April, 2025, issue of Contemporary Pediatrics, with a special focus on pediatric allergy awareness.
Inhaled corticosteroid alternatives for young children after Flovent withdrawal
Flovent was discontinued in January 2024 due to the manufacturer electing to produce only an authorized generic version of the medication.
FDA approves neffy 1 mg for anaphylaxis in children aged 4 years and older
The newly-approved indication is for children aged 4 years and older who weigh 33 < 66 lbs, expanding on the August 9, 2024 approval in children at least 66 lbs.
Full case study: Urticarial rash in a 9-hours-old male
On exam, the patient is found to have circular, slightly raised, blanching, erythematous papules on the lower extremities and abdomen.
FDA approves GSK's meningococcal ABCWY vaccine
The combination vaccine targets 5 groups of the bacteria Neisseria meningitidis (A,B,C,W, AND Y) that cause the most invasive meningococcal disease cases (IMD) globally.
More screen time linked to higher stress, depressive symptoms in adolescence
Higher physical activity and lower screen time in childhood were linked to reduced stress and depression in adolescence, according to a Finnish cohort study.
New data: Viaskin Peanut patch improves treatment benefit through 36 months
In an open-label extension of the EPITOPE phase 3 trial, the Viaskin Peanut patch had continued improvement in toddlers aged 1-3 years through 36 months.
